Eagle Pharmaceuticals, Inc.
EGRX
$1.90
$0.000.00%
OTC PK
| 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | 06/30/2022 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -58.01% | -68.50% | -43.35% | -84.58% | -66.37% |
| Total Receivables | 23.70% | -15.99% | 55.91% | 89.67% | 76.76% |
| Inventory | -26.39% | 77.85% | 118.16% | 585.51% | 595.83% |
| Prepaid Expenses | 10.84% | 66.25% | 151.53% | -72.40% | 66.41% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 134.84% | 17.58% | 88.09% | -18.98% | 10.58% |
| Total Current Assets | -3.71% | -19.85% | 9.36% | 7.78% | 10.80% |
|
|
|||||
| Total Current Assets | -3.71% | -19.85% | 9.36% | 7.78% | 10.80% |
| Net Property, Plant & Equipment | -30.57% | -31.41% | -28.61% | -26.93% | -25.83% |
| Long-term Investments | 4.59% | 13.31% | 13.31% | 5.16% | 8.34% |
| Goodwill | 4.59% | 13.31% | 13.31% | 5.16% | 8.34% |
| Total Other Intangibles | 2.72% | 1,117.30% | 1,085.01% | 982.60% | 877.61% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 36.91% | 44.56% | 50.75% | 37.05% | 20.01% |
| Total Assets | 6.04% | 29.36% | 60.07% | 50.80% | 44.47% |
|
|
|||||
| Total Accounts Payable | -20.67% | 17.91% | 15.59% | 3.92% | 79.34% |
| Total Accrued Expenses | 19.54% | 16.66% | 180.98% | 80.65% | 97.35% |
| Short-term Debt | -- | -- | -75.59% | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -93.90% | -93.67% | 17.19% | 296.45% | 154.19% |
| Total Finance Division Other Current Liabilities | -79.48% | 11.38% | 139.74% | -- | -- |
| Total Other Current Liabilities | -79.48% | 11.38% | 139.74% | -- | -- |
| Total Current Liabilities | -20.50% | -3.77% | 49.36% | 151.55% | 143.96% |
|
|
|||||
| Total Current Liabilities | -20.50% | -3.77% | 49.36% | 151.55% | 143.96% |
| Long-Term Debt | 120.92% | -- | -- | 35.62% | 31.10% |
| Short-term Debt | -- | -- | -75.59% | -- | -- |
| Capital Leases | -62.81% | -58.84% | -- | -38.52% | -32.86% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -24.67% | -- | 30.52% | -- | -- |
| Total Liabilities | 6.27% | 64.42% | 123.35% | 117.94% | 107.18% |
|
|
|||||
| Common Stock & APIC | 4.31% | 12.48% | 12.43% | 12.98% | 13.32% |
| Retained Earnings | 10.82% | -2.22% | 46.98% | 25.93% | 25.99% |
| Treasury Stock & Other | -5.78% | -4.93% | -8.45% | -7.54% | -10.42% |
| Total Common Equity | 5.91% | 12.45% | 32.36% | 25.09% | 22.14% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 5.91% | 12.45% | 32.36% | 25.09% | 22.14% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 5.91% | 12.45% | 32.36% | 25.09% | 22.14% |
|
|
|||||